Abstract
Galectins are a large family of carbohydrate binding proteins with members in nearly every lineage of multicellular life. Through tandem and en-mass genome duplications, over 15 known vertebrate galectins likely evolved from a single common ancestor extant in pre-chordate lineages. While galectins have divergently evolved numerous functions, some of which do not involve carbohydrate recognition, the vast majority of the galectins have retained the conserved ability to bind variably modified polylactosamine (polyLacNAc) residues on glycans that modify proteins and lipids on the surface of host cells and pathogens. In addition to their direct role in microbial killing, many proposed galectin functions in the immune system and cancer involve crosslinking glycosylated receptors and modifying signaling pathways or sensitivity to antigen from the outside in. However, a large body of work has uncovered intracellular galectin functions mediated by carbohydrate- and non-carbohydrate-dependent interactions. In the cytoplasm, galectins can tune intracellular kinase and G-protein-coupled signaling cascades important for nutrient sensing, cell cycle progression, and transformation. Particularly, but interconnected pathways, cytoplasmic galectins serve the innate immune system as sensors of endolysosomal damage, recruiting and assembling the components of autophagosomes during intracellular infection through carbohydrate-dependent and -independent activities. In the nucleus, galectins participate in pre-mRNA splicing perhaps through interactions with non-coding RNAs required for assembly of spliceosomes. Together, studies of galectin function paint a picture of a functionally dynamic protein family recruited during eons of evolution to regulate numerous essential cellular processes in the context of multicellular life.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Abbreviations
- CBP:
-
Carbohydrate binding protein
- CRD:
-
Carbohydrate recognition domain
- ECM:
-
Extracellular matrix
- ER:
-
Endoplasmic reticulum
- GA:
-
Golgi apparatus
- GalNAc:
-
N-acetylgalactosamine
- GALNts:
-
GalNAc transferases
- GBPs:
-
Glycan binding proteins
- PNG:
-
Protein N glycosylation
- Siglecs:
-
Sialic acid-binding immunoglobulin-type lectins
References
Thiemann S, Baum LG (2016) Galectins and immune responses-just how do they do those things they do? Annu Rev Immunol 34:243–264. https://doi.org/10.1146/annurev-immunol-041015-055402
Robinson BS, Arthur CM, Evavold B, Roback E, Kamili NA, Stowell CS, Vallecillo-Zuniga ML, Van Ry PM, Dias-Baruffi M, Cummings RD, Stowell SR (2019) The sweet-side of leukocytes: galectins as master regulators of neutrophil function. Front Immunol 10:1762. https://doi.org/10.3389/fimmu.2019.01762
Johannes L, Jacob R, Leffler H (2018) Galectins at a glance. J Cell Sci 131(9):jcs208884. https://doi.org/10.1242/jcs.208884
Girotti MR, Salatino M, Dalotto-Moreno T, Rabinovich GA (2020) Sweetening the hallmarks of cancer: galectins as multifunctional mediators of tumor progression. J Exp Med 217(2):e20182041. https://doi.org/10.1084/jem.20182041
Teichberg VI, Silman I, Beitsch DD, Resheff G (1975) A beta-D-galactoside binding protein from electric organ tissue of electrophorus electricus. Proc Natl Acad Sci U S A 72(4):1383–1387
Arthur CM, Patel SR, Mener A, Kamili NA, Fasano RM, Meyer E, Winkler AM, Sola-Visner M, Josephson CD, Stowell SR (2015) Innate immunity against molecular mimicry: examining galectin-mediated antimicrobial activity. BioEssays 37(12):1327–1337. https://doi.org/10.1002/bies.201500055
Lowe JB (2001) Glycosylation, immunity, and autoimmunity. Cell 104(6):809–812. https://doi.org/10.1016/s0092-8674(01)00277-x
Barondes SH, Castronovo V, Cooper DN, Cummings RD, Drickamer K, Feizi T, Gitt MA, Hirabayashi J, Hughes C, Kasai K et al (1994) Galectins: a family of animal beta-galactoside-binding lectins. Cell 76(4):597–598. https://doi.org/10.1016/0092-8674(94)90498-7
Arthur CM, Baruffi MD, Cummings RD, Stowell SR (2015) Evolving mechanistic insights into galectin functions. Methods Mol Biol 1207:1–35. https://doi.org/10.1007/978-1-4939-1396-1_1
Mendel G (1865) Experiments in plant hybridization 41
Lauc G, Kristic J, Zoldos V (2014) Glycans—the third revolution in evolution. Front Genet 5:145. https://doi.org/10.3389/fgene.2014.00145
Houzelstein D, Goncalves IR, Fadden AJ, Sidhu SS, Cooper DN, Drickamer K, Leffler H, Poirier F (2004) Phylogenetic analysis of the vertebrate galectin family. Mol Biol Evol 21(7):1177–1187. https://doi.org/10.1093/molbev/msh082
Brewer CF (2002) Thermodynamic binding studies of galectin-1, -3 and -7. Glycoconj J 19(7–9):459–465. https://doi.org/10.1023/B:GLYC.0000014075.62724.d0
Stowell SR, Arthur CM, Mehta P, Slanina KA, Blixt O, Leffler H, Smith DF, Cummings RD (2008) Galectin-1, -2, and -3 exhibit differential recognition of sialylated glycans and blood group antigens. J Biol Chem 283(15):10109–10123. https://doi.org/10.1074/jbc.M709545200
Arthur CM, Rodrigues LC, Baruffi MD, Sullivan HC, Heimburg-Molinaro J, Smith DF, Cummings RD, Stowell SR (2015) Examining galectin binding specificity using glycan microarrays. Methods Mol Biol 1207:115–131. https://doi.org/10.1007/978-1-4939-1396-1_8
Hirabayashi J, Hashidate T, Arata Y, Nishi N, Nakamura T, Hirashima M, Urashima T, Oka T, Futai M, Muller WE, Yagi F, Kasai K (2002) Oligosaccharide specificity of galectins: a search by frontal affinity chromatography. Biochim Biophys Acta 1572(2–3):232–254. https://doi.org/10.1016/s0304-4165(02)00311-2
Sun Y, Cheng L, Gu Y, Xin A, Wu B, Zhou S, Guo S, Liu Y, Diao H, Shi H, Wang G, Tao SC (2016) A human lectin microarray for sperm surface glycosylation analysis. Mol Cell Proteomics 15(9):2839–2851. https://doi.org/10.1074/mcp.M116.059311
Carlsson S, Oberg CT, Carlsson MC, Sundin A, Nilsson UJ, Smith D, Cummings RD, Almkvist J, Karlsson A, Leffler H (2007) Affinity of galectin-8 and its carbohydrate recognition domains for ligands in solution and at the cell surface. Glycobiology 17(6):663–676. https://doi.org/10.1093/glycob/cwm026
Di Lella S, Marti MA, Croci DO, Guardia CM, Diaz-Ricci JC, Rabinovich GA, Caramelo JJ, Estrin DA (2010) Linking the structure and thermal stability of beta-galactoside-binding protein galectin-1 to ligand binding and dimerization equilibria. Biochemistry 49(35):7652–7658. https://doi.org/10.1021/bi100356g
Di Lella S, Sundblad V, Cerliani JP, Guardia CM, Estrin DA, Vasta GR, Rabinovich GA (2011) When galectins recognize glycans: from biochemistry to physiology and back again. Biochemistry 50(37):7842–7857. https://doi.org/10.1021/bi201121m
Stowell SR, Cho M, Feasley CL, Arthur CM, Song X, Colucci JK, Karmakar S, Mehta P, Dias-Baruffi M, McEver RP, Cummings RD (2009) Ligand reduces galectin-1 sensitivity to oxidative inactivation by enhancing dimer formation. J Biol Chem 284(8):4989–4999. https://doi.org/10.1074/jbc.M808925200
Dias-Baruffi M, Zhu H, Cho M, Karmakar S, McEver RP, Cummings RD (2003) Dimeric galectin-1 induces surface exposure of phosphatidylserine and phagocytic recognition of leukocytes without inducing apoptosis. J Biol Chem 278(42):41282–41293. https://doi.org/10.1074/jbc.M306624200
Stowell SR, Arthur CM, Slanina KA, Horton JR, Smith DF, Cummings RD (2008) Dimeric galectin-8 induces phosphatidylserine exposure in leukocytes through polylactosamine recognition by the C-terminal domain. J Biol Chem 283(29):20547–20559. https://doi.org/10.1074/jbc.M802495200
Arthur CM, Rodrigues LC, Baruffi MD, Sullivan HC, Cummings RD, Stowell SR (2015) Detection of phosphatidylserine exposure on leukocytes following treatment with human galectins. Methods Mol Biol 1207:185–200. https://doi.org/10.1007/978-1-4939-1396-1_12
Flores-Ibarra A, Vertesy S, Medrano FJ, Gabius HJ, Romero A (2018) Crystallization of a human galectin-3 variant with two ordered segments in the shortened N-terminal tail. Sci Rep 8(1):9835. https://doi.org/10.1038/s41598-018-28235-x
Mazurek N, Conklin J, Byrd JC, Raz A, Bresalier RS (2000) Phosphorylation of the beta-galactoside-binding protein galectin-3 modulates binding to its ligands. J Biol Chem 275(46):36311–36315. https://doi.org/10.1074/jbc.M003831200
Yoshii T, Fukumori T, Honjo Y, Inohara H, Kim HR, Raz A (2002) Galectin-3 phosphorylation is required for its anti-apoptotic function and cell cycle arrest. J Biol Chem 277(9):6852–6857. https://doi.org/10.1074/jbc.M107668200
Menon S, Kang CM, Beningo KA (2011) Galectin-3 secretion and tyrosine phosphorylation is dependent on the calpain small subunit, Calpain 4. Biochem Biophys Res Commun 410(1):91–96. https://doi.org/10.1016/j.bbrc.2011.05.112
Kamili NA, Arthur CM, Gerner-Smidt C, Tafesse E, Blenda A, Dias-Baruffi M, Stowell SR (2016) Key regulators of galectin-glycan interactions. Proteomics 16(24):3111–3125. https://doi.org/10.1002/pmic.201600116
Ju T, Lanneau GS, Gautam T, Wang Y, Xia B, Stowell SR, Willard MT, Wang W, Xia JY, Zuna RE, Laszik Z, Benbrook DM, Hanigan MH, Cummings RD (2008) Human tumor antigens Tn and sialyl Tn arise from mutations in Cosmc. Cancer Res 68(6):1636–1646. https://doi.org/10.1158/0008-5472.CAN-07-2345
Stowell SR, Ju T, Cummings RD (2015) Protein glycosylation in cancer. Annu Rev Pathol 10:473–510. https://doi.org/10.1146/annurev-pathol-012414-040438
Arthur CM, Cummings RD, Stowell SR (2014) Using glycan microarrays to understand immunity. Curr Opin Chem Biol 18:55–61. https://doi.org/10.1016/j.cbpa.2013.12.017
Colnot C, Fowlis D, Ripoche MA, Bouchaert I, Poirier F (1998) Embryonic implantation in galectin 1/galectin 3 double mutant mice. Dev Dyn 211(4):306–313. https://doi.org/10.1002/(SICI)1097-0177(199804)211:4<306::AID-AJA2>3.0.CO;2-L
Poirier F, Robertson EJ (1993) Normal development of mice carrying a null mutation in the gene encoding the L14 S-type lectin. Development 119(4):1229–1236
Poirier F, Timmons PM, Chan CT, Guenet JL, Rigby PW (1992) Expression of the L14 lectin during mouse embryogenesis suggests multiple roles during pre- and post-implantation development. Development 115(1):143–155
Colnot C, Ripoche MA, Scaerou F, Foulis D, Poirier F (1996) Galectins in mouse embryogenesis. Biochem Soc Trans 24(1):141–146. https://doi.org/10.1042/bst0240141
Wada J, Ota K, Kumar A, Wallner EI, Kanwar YS (1997) Developmental regulation, expression, and apoptotic potential of galectin-9, a beta-galactoside binding lectin. J Clin Invest 99(10):2452–2461. https://doi.org/10.1172/JCI119429
Benvenuto G, Carpentieri ML, Salvatore P, Cindolo L, Bruni CB, Chiariotti L (1996) Cell-specific transcriptional regulation and reactivation of galectin-1 gene expression are controlled by DNA methylation of the promoter region. Mol Cell Biol 16(6):2736–2743. https://doi.org/10.1128/mcb.16.6.2736
Toscano MA, Campagna L, Molinero LL, Cerliani JP, Croci DO, Ilarregui JM, Fuertes MB, Nojek IM, Fededa JP, Zwirner NW, Costas MA, Rabinovich GA (2011) Nuclear factor (NF)-kappaB controls expression of the immunoregulatory glycan-binding protein galectin-1. Mol Immunol 48(15–16):1940–1949. https://doi.org/10.1016/j.molimm.2011.05.021
Than NG, Romero R, Erez O, Weckle A, Tarca AL, Hotra J, Abbas A, Han YM, Kim SS, Kusanovic JP, Gotsch F, Hou Z, Santolaya-Forgas J, Benirschke K, Papp Z, Grossman LI, Goodman M, Wildman DE (2008) Emergence of hormonal and redox regulation of galectin-1 in placental mammals: implication in maternal-fetal immune tolerance. Proc Natl Acad Sci U S A 105(41):15819–15824. https://doi.org/10.1073/pnas.0807606105
Than NG, Romero R, Xu Y, Erez O, Xu Z, Bhatti G, Leavitt R, Chung TH, El-Azzamy H, LaJeunesse C, Wang B, Balogh A, Szalai G, Land S, Dong Z, Hassan SS, Chaiworapongsa T, Krispin M, Kim CJ, Tarca AL, Papp Z, Bohn H (2014) Evolutionary origins of the placental expression of chromosome 19 cluster galectins and their complex dysregulation in preeclampsia. Placenta 35(11):855–865. https://doi.org/10.1016/j.placenta.2014.07.015
Ely ZA, Moon JM, Sliwoski GR, Sangha AK, Shen XX, Labella AL, Meiler J, Capra JA, Rokas A (2019) The impact of natural selection on the evolution and function of placentally expressed galectins. Genome Biol Evol 11(9):2574–2592. https://doi.org/10.1093/gbe/evz183
Than NG, Romero R, Goodman M, Weckle A, Xing J, Dong Z, Xu Y, Tarquini F, Szilagyi A, Gal P, Hou Z, Tarca AL, Kim CJ, Kim JS, Haidarian S, Uddin M, Bohn H, Benirschke K, Santolaya-Forgas J, Grossman LI, Erez O, Hassan SS, Zavodszky P, Papp Z, Wildman DE (2009) A primate subfamily of galectins expressed at the maternal-fetal interface that promote immune cell death. Proc Natl Acad Sci U S A 106(24):9731–9736. https://doi.org/10.1073/pnas.0903568106
Than NG, Romero R, Kim CJ, McGowen MR, Papp Z, Wildman DE (2012) Galectins: guardians of eutherian pregnancy at the maternal-fetal interface. Trends Endocrinol Metab 23(1):23–31. https://doi.org/10.1016/j.tem.2011.09.003
Koopman LA, Kopcow HD, Rybalov B, Boyson JE, Orange JS, Schatz F, Masch R, Lockwood CJ, Schachter AD, Park PJ, Strominger JL (2003) Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential. J Exp Med 198(8):1201–1212. https://doi.org/10.1084/jem.20030305
Garin MI, Chu CC, Golshayan D, Cernuda-Morollon E, Wait R, Lechler RI (2007) Galectin-1: a key effector of regulation mediated by CD4+CD25+ T cells. Blood 109(5):2058–2065. https://doi.org/10.1182/blood-2006-04-016451
Liu FT (2000) Galectins: a new family of regulators of inflammation. Clin Immunol 97(2):79–88. https://doi.org/10.1006/clim.2000.4912
Hsu DK, Hammes SR, Kuwabara I, Greene WC, Liu FT (1996) Human T lymphotropic virus-I infection of human T lymphocytes induces expression of the beta-galactoside-binding lectin, galectin-3. Am J Pathol 148(5):1661–1670
Ackerman SJ, Corrette SE, Rosenberg HF, Bennett JC, Mastrianni DM, Nicholson-Weller A, Weller PF, Chin DT, Tenen DG (1993) Molecular cloning and characterization of human eosinophil Charcot-Leyden crystal protein (lysophospholipase). Similarities to IgE binding proteins and the S-type animal lectin superfamily. J Immunol 150(2):456–468
Dor PJ, Ackerman SJ, Gleich GJ (1984) Charcot-Leyden crystal protein and eosinophil granule major basic protein in sputum of patients with respiratory diseases. Am Rev Respir Dis 130(6):1072–1077. https://doi.org/10.1164/arrd.1984.130.6.1072
Swaminathan GJ, Leonidas DD, Savage MP, Ackerman SJ, Acharya KR (1999) Selective recognition of mannose by the human eosinophil Charcot-Leyden crystal protein (galectin-10): a crystallographic study at 1.8 A resolution. Biochemistry 38(42):13837–13843. https://doi.org/10.1021/bi990756e
Yang RY, Yu L, Graham JL, Hsu DK, Lloyd KC, Havel PJ, Liu FT (2011) Ablation of a galectin preferentially expressed in adipocytes increases lipolysis, reduces adiposity, and improves insulin sensitivity in mice. Proc Natl Acad Sci U S A 108(46):18696–18701. https://doi.org/10.1073/pnas.1109065108
Dagher SF, Wang JL, Patterson RJ (1995) Identification of galectin-3 as a factor in pre-mRNA splicing. Proc Natl Acad Sci U S A 92(4):1213–1217. https://doi.org/10.1073/pnas.92.4.1213
Vyakarnam A, Lenneman AJ, Lakkides KM, Patterson RJ, Wang JL (1998) A comparative nuclear localization study of galectin-1 with other splicing components. Exp Cell Res 242(2):419–428. https://doi.org/10.1006/excr.1998.4111
Wang W, Park JW, Wang JL, Patterson RJ (2006) Immunoprecipitation of spliceosomal RNAs by antisera to galectin-1 and galectin-3. Nucleic Acids Res 34(18):5166–5174. https://doi.org/10.1093/nar/gkl673
Nakahara S, Hogan V, Inohara H, Raz A (2006) Importin-mediated nuclear translocation of galectin-3. J Biol Chem 281(51):39649–39659. https://doi.org/10.1074/jbc.M608069200
Huflejt ME, Turck CW, Lindstedt R, Barondes SH, Leffler H (1993) L-29, a soluble lactose-binding lectin, is phosphorylated on serine 6 and serine 12 in vivo and by casein kinase I. J Biol Chem 268(35):26712–26718
Wang JL, Gray RM, Haudek KC, Patterson RJ (2004) Nucleocytoplasmic lectins. Biochim Biophys Acta 1673(1–2):75–93. https://doi.org/10.1016/j.bbagen.2004.03.013
Haudek KC, Voss PG, Locascio LE, Wang JL, Patterson RJ (2009) A mechanism for incorporation of galectin-3 into the spliceosome through its association with U1 snRNP. Biochemistry 48(32):7705–7712. https://doi.org/10.1021/bi900071b
Gray RM, Davis MJ, Ruby KM, Voss PG, Patterson RJ, Wang JL (2008) Distinct effects on splicing of two monoclonal antibodies directed against the amino-terminal domain of galectin-3. Arch Biochem Biophys 475(2):100–108. https://doi.org/10.1016/j.abb.2008.04.010
Park JW, Voss PG, Grabski S, Wang JL, Patterson RJ (2001) Association of galectin-1 and galectin-3 with Gemin4 in complexes containing the SMN protein. Nucleic Acids Res 29(17):3595–3602. https://doi.org/10.1093/nar/29.17.3595
Coppin L, Vincent A, Frenois F, Duchene B, Lahdaoui F, Stechly L, Renaud F, Villenet C, Van Seuningen I, Leteurtre E, Dion J, Grandjean C, Poirier F, Figeac M, Delacour D, Porchet N, Pigny P (2017) Galectin-3 is a non-classic RNA binding protein that stabilizes the mucin MUC4 mRNA in the cytoplasm of cancer cells. Sci Rep 7:43927. https://doi.org/10.1038/srep43927
Bafna S, Kaur S, Batra SK (2010) Membrane-bound mucins: the mechanistic basis for alterations in the growth and survival of cancer cells. Oncogene 29(20):2893–2904. https://doi.org/10.1038/onc.2010.87
Golling G, Amsterdam A, Sun Z, Antonelli M, Maldonado E, Chen W, Burgess S, Haldi M, Artzt K, Farrington S, Lin SY, Nissen RM, Hopkins N (2002) Insertional mutagenesis in zebrafish rapidly identifies genes essential for early vertebrate development. Nat Genet 31(2):135–140. https://doi.org/10.1038/ng896
Yang RY, Hsu DK, Liu FT (1996) Expression of galectin-3 modulates T-cell growth and apoptosis. Proc Natl Acad Sci U S A 93(13):6737–6742. https://doi.org/10.1073/pnas.93.13.6737
Akahani S, Nangia-Makker P, Inohara H, Kim HR, Raz A (1997) Galectin-3: a novel antiapoptotic molecule with a functional BH1 (NWGR) domain of Bcl-2 family. Cancer Res 57(23):5272–5276
Wang Y, Balan V, Gao X, Reddy PG, Kho D, Tait L, Raz A (2013) The significance of galectin-3 as a new basal cell marker in prostate cancer. Cell Death Dis 4:e753. https://doi.org/10.1038/cddis.2013.277
Cheng D, Liang B, Li Y (2015) Serum galectin-3 as a potential marker for gastric cancer. Med Sci Monit 21:755–760. https://doi.org/10.12659/MSM.892386
Mazurek N, Byrd JC, Sun Y, Hafley M, Ramirez K, Burks J, Bresalier RS (2012) Cell-surface galectin-3 confers resistance to TRAIL by impeding trafficking of death receptors in metastatic colon adenocarcinoma cells. Cell Death Differ 19(3):523–533. https://doi.org/10.1038/cdd.2011.123
Kobayashi T, Shimura T, Yajima T, Kubo N, Araki K, Wada W, Tsutsumi S, Suzuki H, Kuwano H, Raz A (2011) Transient silencing of galectin-3 expression promotes both in vitro and in vivo drug-induced apoptosis of human pancreatic carcinoma cells. Clin Exp Metastasis 28(4):367–376. https://doi.org/10.1007/s10585-011-9376-x
Califice S, Castronovo V, Bracke M, van den Brule F (2004) Dual activities of galectin-3 in human prostate cancer: tumor suppression of nuclear galectin-3 vs tumor promotion of cytoplasmic galectin-3. Oncogene 23(45):7527–7536. https://doi.org/10.1038/sj.onc.1207997
Takenaka Y, Fukumori T, Yoshii T, Oka N, Inohara H, Kim HR, Bresalier RS, Raz A (2004) Nuclear export of phosphorylated galectin-3 regulates its antiapoptotic activity in response to chemotherapeutic drugs. Mol Cell Biol 24(10):4395–4406. https://doi.org/10.1128/mcb.24.10.4395-4406.2004
Bernerd F, Sarasin A, Magnaldo T (1999) Galectin-7 overexpression is associated with the apoptotic process in UVB-induced sunburn keratinocytes. Proc Natl Acad Sci U S A 96(20):11329–11334. https://doi.org/10.1073/pnas.96.20.11329
Cooper DN, Barondes SH (1990) Evidence for export of a muscle lectin from cytosol to extracellular matrix and for a novel secretory mechanism. J Cell Biol 110(5):1681–1691. https://doi.org/10.1083/jcb.110.5.1681
Obino D, Fetler L, Soza A, Malbec O, Saez JJ, Labarca M, Oyanadel C, Del Valle BF, Goles N, Chikina A, Lankar D, Segovia-Miranda F, Garcia C, Leger T, Gonzalez A, Espeli M, Lennon-Dumenil AM, Yuseff MI (2018) Galectin-8 favors the presentation of surface-tethered antigens by stabilizing the B cell immune synapse. Cell Rep 25(11):3110–3122 e3116. https://doi.org/10.1016/j.celrep.2018.11.052
Cerri DG, Rodrigues LC, Stowell SR, Araujo DD, Coelho MC, Oliveira SR, Bizario JC, Cummings RD, Dias-Baruffi M, Costa MC (2008) Degeneration of dystrophic or injured skeletal muscles induces high expression of galectin-1. Glycobiology 18(11):842–850. https://doi.org/10.1093/glycob/cwn079
Vallecillo-Zuniga ML, Rathgeber MF, Poulson PD, Hayes S, Luddington JS, Gill HN, Teynor M, Kartchner BC, Valdoz J, Stowell C, Markham AR, Arthur C, Stowell S, Van Ry PM (2020) Treatment with galectin-1 improves myogenic potential and membrane repair in dysferlin-deficient models. PLoS One 15(9):e0238441. https://doi.org/10.1371/journal.pone.0238441
Seelenmeyer C, Wegehingel S, Tews I, Kunzler M, Aebi M, Nickel W (2005) Cell surface counter receptors are essential components of the unconventional export machinery of galectin-1. J Cell Biol 171(2):373–381. https://doi.org/10.1083/jcb.200506026
Cho M, Cummings RD (1995) Galectin-1, a beta-galactoside-binding lectin in Chinese hamster ovary cells. II. Localization and biosynthesis. J Biol Chem 270(10):5207–5212. https://doi.org/10.1074/jbc.270.10.5207
Banfer S, Schneider D, Dewes J, Strauss MT, Freibert SA, Heimerl T, Maier UG, Elsasser HP, Jungmann R, Jacob R (2018) Molecular mechanism to recruit galectin-3 into multivesicular bodies for polarized exosomal secretion. Proc Natl Acad Sci U S A 115(19):E4396–E4405. https://doi.org/10.1073/pnas.1718921115
Thurston TL, Wandel MP, von Muhlinen N, Foeglein A, Randow F (2012) Galectin 8 targets damaged vesicles for autophagy to defend cells against bacterial invasion. Nature 482(7385):414–418. https://doi.org/10.1038/nature10744
Patnaik SK, Potvin B, Carlsson S, Sturm D, Leffler H, Stanley P (2006) Complex N-glycans are the major ligands for galectin-1, -3, and -8 on Chinese hamster ovary cells. Glycobiology 16(4):305–317. https://doi.org/10.1093/glycob/cwj063
Nabi IR, Shankar J, Dennis JW (2015) The galectin lattice at a glance. J Cell Sci 128(13):2213–2219. https://doi.org/10.1242/jcs.151159
Apweiler R, Hermjakob H, Sharon N (1999) On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database. Biochim Biophys Acta 1473(1):4–8. https://doi.org/10.1016/s0304-4165(99)00165-8
Lau KS, Partridge EA, Grigorian A, Silvescu CI, Reinhold VN, Demetriou M, Dennis JW (2007) Complex N-glycan number and degree of branching cooperate to regulate cell proliferation and differentiation. Cell 129(1):123–134. https://doi.org/10.1016/j.cell.2007.01.049
Smith LK, Boukhaled GM, Condotta SA, Mazouz S, Guthmiller JJ, Vijay R, Butler NS, Bruneau J, Shoukry NH, Krawczyk CM, Richer MJ (2018) Interleukin-10 directly inhibits CD8(+) T cell function by enhancing N-glycan branching to decrease antigen sensitivity. Immunity 48(2):299–312 e295. https://doi.org/10.1016/j.immuni.2018.01.006
Demetriou M, Granovsky M, Quaggin S, Dennis JW (2001) Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation. Nature 409(6821):733–739. https://doi.org/10.1038/35055582
Mkhikian H, Grigorian A, Li CF, Chen HL, Newton B, Zhou RW, Beeton C, Torossian S, Tatarian GG, Lee SU, Lau K, Walker E, Siminovitch KA, Chandy KG, Yu Z, Dennis JW, Demetriou M (2011) Genetics and the environment converge to dysregulate N-glycosylation in multiple sclerosis. Nat Commun 2:334. https://doi.org/10.1038/ncomms1333
Li CF, Zhou RW, Mkhikian H, Newton BL, Yu Z, Demetriou M (2013) Hypomorphic MGAT5 polymorphisms promote multiple sclerosis cooperatively with MGAT1 and interleukin-2 and 7 receptor variants. J Neuroimmunol 256(1–2):71–76. https://doi.org/10.1016/j.jneuroim.2012.12.008
Yu Z, Li CF, Mkhikian H, Zhou RW, Newton BL, Demetriou M (2014) Family studies of type 1 diabetes reveal additive and epistatic effects between MGAT1 and three other polymorphisms. Genes Immun 15(4):218–223. https://doi.org/10.1038/gene.2014.7
Levi G, Tarrab-Hazdai R, Teichberg VI (1983) Prevention and therapy with electrolectin of experimental autoimmune myasthenia gravis in rabbits. Eur J Immunol 13(6):500–507. https://doi.org/10.1002/eji.1830130613
Baum LG, Pang M, Perillo NL, Wu T, Delegeane A, Uittenbogaart CH, Fukuda M, Seilhamer JJ (1995) Human thymic epithelial cells express an endogenous lectin, galectin-1, which binds to core 2 O-glycans on thymocytes and T lymphoblastoid cells. J Exp Med 181(3):877–887. https://doi.org/10.1084/jem.181.3.877
Lee-Sundlov MM, Stowell SR, Hoffmeister KM (2020) Multifaceted role of glycosylation in transfusion medicine, platelets, and red blood cells. J Thromb Haemost 18(7):1535–1547. https://doi.org/10.1111/jth.14874
Gendronneau G, Sidhu SS, Delacour D, Dang T, Calonne C, Houzelstein D, Magnaldo T, Poirier F (2008) Galectin-7 in the control of epidermal homeostasis after injury. Mol Biol Cell 19(12):5541–5549. https://doi.org/10.1091/mbc.E08-02-0166
Panjwani N (2014) Role of galectins in re-epithelialization of wounds. Ann Transl Med 2(9):89. https://doi.org/10.3978/j.issn.2305-5839.2014.09.09
Robinson BS, Saeedi B, Arthur CM, Owens J, Naudin C, Ahmed N, Luo L, Jones R, Neish A, Stowell SR (2020) Galectin-9 is a novel regulator of epithelial restitution. Am J Pathol 190(8):1657–1666. https://doi.org/10.1016/j.ajpath.2020.04.010
Thijssen VL, Postel R, Brandwijk RJ, Dings RP, Nesmelova I, Satijn S, Verhofstad N, Nakabeppu Y, Baum LG, Bakkers J, Mayo KH, Poirier F, Griffioen AW (2006) Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy. Proc Natl Acad Sci U S A 103(43):15975–15980. https://doi.org/10.1073/pnas.0603883103
D’Haene N, Sauvage S, Maris C, Adanja I, Le Mercier M, Decaestecker C, Baum L, Salmon I (2013) VEGFR1 and VEGFR2 involvement in extracellular galectin-1- and galectin-3-induced angiogenesis. PLoS One 8(6):e67029. https://doi.org/10.1371/journal.pone.0067029
Nangia-Makker P, Honjo Y, Sarvis R, Akahani S, Hogan V, Pienta KJ, Raz A (2000) Galectin-3 induces endothelial cell morphogenesis and angiogenesis. Am J Pathol 156(3):899–909. https://doi.org/10.1016/S0002-9440(10)64959-0
Freitag N, Tirado-Gonzalez I, Barrientos G, Herse F, Thijssen VL, Weedon-Fekjaer SM, Schulz H, Wallukat G, Klapp BF, Nevers T, Sharma S, Staff AC, Dechend R, Blois SM (2013) Interfering with Gal-1-mediated angiogenesis contributes to the pathogenesis of preeclampsia. Proc Natl Acad Sci U S A 110(28):11451–11456. https://doi.org/10.1073/pnas.1303707110
Romaniuk MA, Tribulatti MV, Cattaneo V, Lapponi MJ, Molinas FC, Campetella O, Schattner M (2010) Human platelets express and are activated by galectin-8. Biochem J 432(3):535–547. https://doi.org/10.1042/BJ20100538
Pacienza N, Pozner RG, Bianco GA, D’Atri LP, Croci DO, Negrotto S, Malaver E, Gomez RM, Rabinovich GA, Schattner M (2008) The immunoregulatory glycan-binding protein galectin-1 triggers human platelet activation. FASEB J 22(4):1113–1123. https://doi.org/10.1096/fj.07-9524com
Romaniuk MA, Croci DO, Lapponi MJ, Tribulatti MV, Negrotto S, Poirier F, Campetella O, Rabinovich GA, Schattner M (2012) Binding of galectin-1 to alphaIIbbeta(3) integrin triggers “outside-in” signals, stimulates platelet activation, and controls primary hemostasis. FASEB J 26(7):2788–2798. https://doi.org/10.1096/fj.11-197541
Pylayeva-Gupta Y, Grabocka E, Bar-Sagi D (2011) RAS oncogenes: weaving a tumorigenic web. Nat Rev Cancer 11(11):761–774. https://doi.org/10.1038/nrc3106
Paz A, Haklai R, Elad-Sfadia G, Ballan E, Kloog Y (2001) Galectin-1 binds oncogenic H-Ras to mediate Ras membrane anchorage and cell transformation. Oncogene 20(51):7486–7493. https://doi.org/10.1038/sj.onc.1204950
Elad-Sfadia G, Haklai R, Balan E, Kloog Y (2004) Galectin-3 augments K-Ras activation and triggers a Ras signal that attenuates ERK but not phosphoinositide 3-kinase activity. J Biol Chem 279(33):34922–34930. https://doi.org/10.1074/jbc.M312697200
Shalom-Feuerstein R, Cooks T, Raz A, Kloog Y (2005) Galectin-3 regulates a molecular switch from N-Ras to K-Ras usage in human breast carcinoma cells. Cancer Res 65(16):7292–7300. https://doi.org/10.1158/0008-5472.CAN-05-0775
Vuong L, Kouverianou E, Rooney CM, McHugh BJ, Howie SEM, Gregory CD, Forbes SJ, Henderson NC, Zetterberg FR, Nilsson UJ, Leffler H, Ford P, Pedersen A, Gravelle L, Tantawi S, Schambye H, Sethi T, MacKinnon AC (2019) An orally active galectin-3 antagonist inhibits lung adenocarcinoma growth and augments response to PD-L1 blockade. Cancer Res 79(7):1480–1492. https://doi.org/10.1158/0008-5472.CAN-18-2244
Chung LY, Tang SJ, Sun GH, Chou TY, Yeh TS, Yu SL, Sun KH (2012) Galectin-1 promotes lung cancer progression and chemoresistance by upregulating p38 MAPK, ERK, and cyclooxygenase-2. Clin Cancer Res 18(15):4037–4047. https://doi.org/10.1158/1078-0432.CCR-11-3348
Banh A, Zhang J, Cao H, Bouley DM, Kwok S, Kong C, Giaccia AJ, Koong AC, Le QT (2011) Tumor galectin-1 mediates tumor growth and metastasis through regulation of T-cell apoptosis. Cancer Res 71(13):4423–4431. https://doi.org/10.1158/0008-5472.CAN-10-4157
Nambiar DK, Aguilera T, Cao H, Kwok S, Kong C, Bloomstein J, Wang Z, Rangan VS, Jiang D, von Eyben R, Liang R, Agarwal S, Colevas AD, Korman A, Allen CT, Uppaluri R, Koong AC, Giaccia A, Le QT (2019) Galectin-1-driven T cell exclusion in the tumor endothelium promotes immunotherapy resistance. J Clin Invest 129(12):5553–5567. https://doi.org/10.1172/JCI129025
Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pages C, Tosolini M, Camus M, Berger A, Wind P, Zinzindohoue F, Bruneval P, Cugnenc PH, Trajanoski Z, Fridman WH, Pages F (2006) Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313(5795):1960–1964. https://doi.org/10.1126/science.1129139
Herbst RS, Soria JC, Kowanetz M, Fine GD, Hamid O, Gordon MS, Sosman JA, McDermott DF, Powderly JD, Gettinger SN, Kohrt HE, Horn L, Lawrence DP, Rost S, Leabman M, Xiao Y, Mokatrin A, Koeppen H, Hegde PS, Mellman I, Chen DS, Hodi FS (2014) Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients. Nature 515(7528):563–567. https://doi.org/10.1038/nature14011
Peranzoni E, Lemoine J, Vimeux L, Feuillet V, Barrin S, Kantari-Mimoun C, Bercovici N, Guerin M, Biton J, Ouakrim H, Regnier F, Lupo A, Alifano M, Damotte D, Donnadieu E (2018) Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti-PD-1 treatment. Proc Natl Acad Sci U S A 115(17):E4041–E4050. https://doi.org/10.1073/pnas.1720948115
Savas P, Virassamy B, Ye C, Salim A, Mintoff CP, Caramia F, Salgado R, Byrne DJ, Teo ZL, Dushyanthen S, Byrne A, Wein L, Luen SJ, Poliness C, Nightingale SS, Skandarajah AS, Gyorki DE, Thornton CM, Beavis PA, Fox SB, Kathleen Cuningham Foundation Consortium for Research into Familial Breast C, Darcy PK, Speed TP, Mackay LK, Neeson PJ, Loi S (2018) Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis. Nat Med 24(7):986–993. https://doi.org/10.1038/s41591-018-0078-7
Thijssen VL, Heusschen R, Caers J, Griffioen AW (2015) Galectin expression in cancer diagnosis and prognosis: a systematic review. Biochim Biophys Acta 1855(2):235–247. https://doi.org/10.1016/j.bbcan.2015.03.003
Gordon-Alonso M, Hirsch T, Wildmann C, van der Bruggen P (2017) Galectin-3 captures interferon-gamma in the tumor matrix reducing chemokine gradient production and T-cell tumor infiltration. Nat Commun 8(1):793. https://doi.org/10.1038/s41467-017-00925-6
Santucci L, Fiorucci S, Cammilleri F, Servillo G, Federici B, Morelli A (2000) Galectin-1 exerts immunomodulatory and protective effects on concanavalin A-induced hepatitis in mice. Hepatology 31(2):399–406. https://doi.org/10.1002/hep.510310220
Santucci L, Fiorucci S, Rubinstein N, Mencarelli A, Palazzetti B, Federici B, Rabinovich GA, Morelli A (2003) Galectin-1 suppresses experimental colitis in mice. Gastroenterology 124(5):1381–1394. https://doi.org/10.1016/s0016-5085(03)00267-1
Toscano MA, Commodaro AG, Ilarregui JM, Bianco GA, Liberman A, Serra HM, Hirabayashi J, Rizzo LV, Rabinovich GA (2006) Galectin-1 suppresses autoimmune retinal disease by promoting concomitant Th2- and T regulatory-mediated anti-inflammatory responses. J Immunol 176(10):6323–6332. https://doi.org/10.4049/jimmunol.176.10.6323
Baum LG, Blackall DP, Arias-Magallano S, Nanigian D, Uh SY, Browne JM, Hoffmann D, Emmanouilides CE, Territo MC, Baldwin GC (2003) Amelioration of graft versus host disease by galectin-1. Clin Immunol 109(3):295–307. https://doi.org/10.1016/j.clim.2003.08.003
Perillo NL, Pace KE, Seilhamer JJ, Baum LG (1995) Apoptosis of T cells mediated by galectin-1. Nature 378(6558):736–739. https://doi.org/10.1038/378736a0
Clemente T, Vieira NJ, Cerliani JP, Adrain C, Luthi A, Dominguez MR, Yon M, Barrence FC, Riul TB, Cummings RD, Zorn TM, Amigorena S, Dias-Baruffi M, Rodrigues MM, Martin SJ, Rabinovich GA, Amarante-Mendes GP (2017) Proteomic and functional analysis identifies galectin-1 as a novel regulatory component of the cytotoxic granule machinery. Cell Death Dis 8(12):e3176. https://doi.org/10.1038/cddis.2017.506
Stillman BN, Hsu DK, Pang M, Brewer CF, Johnson P, Liu FT, Baum LG (2006) Galectin-3 and galectin-1 bind distinct cell surface glycoprotein receptors to induce T cell death. J Immunol 176(2):778–789. https://doi.org/10.4049/jimmunol.176.2.778
Thiemann S, Man JH, Chang MH, Lee B, Baum LG (2015) Galectin-1 regulates tissue exit of specific dendritic cell populations. J Biol Chem 290(37):22662–22677. https://doi.org/10.1074/jbc.M115.644799
Ilarregui JM, Croci DO, Bianco GA, Toscano MA, Salatino M, Vermeulen ME, Geffner JR, Rabinovich GA (2009) Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10. Nat Immunol 10(9):981–991. https://doi.org/10.1038/ni.1772
Im SJ, Hashimoto M, Gerner MY, Lee J, Kissick HT, Burger MC, Shan Q, Hale JS, Lee J, Nasti TH, Sharpe AH, Freeman GJ, Germain RN, Nakaya HI, Xue HH, Ahmed R (2016) Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy. Nature 537(7620):417–421. https://doi.org/10.1038/nature19330
Robertson MW, Albrandt K, Keller D, Liu FT (1990) Human IgE-binding protein: a soluble lectin exhibiting a highly conserved interspecies sequence and differential recognition of IgE glycoforms. Biochemistry 29(35):8093–8100. https://doi.org/10.1021/bi00487a015
Truong MJ, Gruart V, Kusnierz JP, Papin JP, Loiseau S, Capron A, Capron M (1993) Human neutrophils express immunoglobulin E (IgE)-binding proteins (Mac-2/epsilon BP) of the S-type lectin family: role in IgE-dependent activation. J Exp Med 177(1):243–248
Stowell SR, Karmakar S, Stowell CJ, Dias-Baruffi M, McEver RP, Cummings RD (2007) Human galectin-1, -2, and -4 induce surface exposure of phosphatidylserine in activated human neutrophils but not in activated T cells. Blood 109(1):219–227. https://doi.org/10.1182/blood-2006-03-007153
Stowell SR, Qian Y, Karmakar S, Koyama NS, Dias-Baruffi M, Leffler H, McEver RP, Cummings RD (2008) Differential roles of galectin-1 and galectin-3 in regulating leukocyte viability and cytokine secretion. J Immunol 180(5):3091–3102
Stowell SR, Karmakar S, Arthur CM, Ju T, Rodrigues LC, Riul TB, Dias-Baruffi M, Miner J, McEver RP, Cummings RD (2009) Galectin-1 induces reversible phosphatidylserine exposure at the plasma membrane. Mol Biol Cell 20(5):1408–1418. https://doi.org/10.1091/mbc.E08-07-0786
Tian J, Yang G, Chen HY, Hsu DK, Tomilov A, Olson KA, Dehnad A, Fish SR, Cortopassi G, Zhao B, Liu FT, Gershwin ME, Torok NJ, Jiang JX (2016) Galectin-3 regulates inflammasome activation in cholestatic liver injury. FASEB J 30(12):4202–4213. https://doi.org/10.1096/fj.201600392RR
Chen YJ, Wang SF, Weng IC, Hong MH, Lo TH, Jan JT, Hsu LC, Chen HY, Liu FT (2018) Galectin-3 enhances avian H5N1 influenza a virus-induced pulmonary inflammation by promoting NLRP3 inflammasome activation. Am J Pathol 188(4):1031–1042. https://doi.org/10.1016/j.ajpath.2017.12.014
Querol Cano L, Tagit O, Dolen Y, van Duffelen A, Dieltjes S, Buschow SI, Niki T, Hirashima M, Joosten B, van den Dries K, Cambi A, Figdor CG, van Spriel AB (2019) Intracellular galectin-9 controls dendritic cell function by maintaining plasma membrane rigidity. iScience 22:240–255. https://doi.org/10.1016/j.isci.2019.11.019
Henderson NC, Mackinnon AC, Farnworth SL, Kipari T, Haslett C, Iredale JP, Liu FT, Hughes J, Sethi T (2008) Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis. Am J Pathol 172(2):288–298. https://doi.org/10.2353/ajpath.2008.070726
Di Gregoli K, Somerville M, Bianco R, Thomas AC, Frankow A, Newby AC, George SJ, Jackson CL, Johnson JL (2020) Galectin-3 identifies a subset of macrophages with a potential beneficial role in atherosclerosis. Arterioscler Thromb Vasc Biol 40(6):1491–1509. https://doi.org/10.1161/ATVBAHA.120.314252
MacKinnon AC, Farnworth SL, Hodkinson PS, Henderson NC, Atkinson KM, Leffler H, Nilsson UJ, Haslett C, Forbes SJ, Sethi T (2008) Regulation of alternative macrophage activation by galectin-3. J Immunol 180(4):2650–2658. https://doi.org/10.4049/jimmunol.180.4.2650
Takahashi K, Ezekowitz RA (2005) The role of the mannose-binding lectin in innate immunity. Clin Infect Dis 41(Suppl 7):S440–S444. https://doi.org/10.1086/431987
Garred P, Larsen F, Seyfarth J, Fujita R, Madsen HO (2006) Mannose-binding lectin and its genetic variants. Genes Immun 7(2):85–94. https://doi.org/10.1038/sj.gene.6364283
Brown GD (2006) Dectin-1: a signalling non-TLR pattern-recognition receptor. Nat Rev Immunol 6(1):33–43. https://doi.org/10.1038/nri1745
Li FY, Weng IC, Lin CH, Kao MC, Wu MS, Chen HY, Liu FT (2019) Helicobacter pylori induces intracellular galectin-8 aggregation around damaged lysosomes within gastric epithelial cells in a host O-glycan-dependent manner. Glycobiology 29(2):151–162. https://doi.org/10.1093/glycob/cwy095
Chauhan S, Kumar S, Jain A, Ponpuak M, Mudd MH, Kimura T, Choi SW, Peters R, Mandell M, Bruun JA, Johansen T, Deretic V (2016) TRIMs and galectins globally cooperate and TRIM16 and galectin-3 co-direct autophagy in endomembrane damage homeostasis. Dev Cell 39(1):13–27. https://doi.org/10.1016/j.devcel.2016.08.003
Paz I, Sachse M, Dupont N, Mounier J, Cederfur C, Enninga J, Leffler H, Poirier F, Prevost MC, Lafont F, Sansonetti P (2010) Galectin-3, a marker for vacuole lysis by invasive pathogens. Cell Microbiol 12(4):530–544. https://doi.org/10.1111/j.1462-5822.2009.01415.x
Vasta GR (2009) Roles of galectins in infection. Nat Rev Microbiol 7(6):424–438. https://doi.org/10.1038/nrmicro2146
Stowell SR, Arthur CM, Dias-Baruffi M, Rodrigues LC, Gourdine JP, Heimburg-Molinaro J, Ju T, Molinaro RJ, Rivera-Marrero C, Xia B, Smith DF, Cummings RD (2010) Innate immune lectins kill bacteria expressing blood group antigen. Nat Med 16(3):295–301. https://doi.org/10.1038/nm.2103
Stowell SR, Arthur CM, McBride R, Berger O, Razi N, Heimburg-Molinaro J, Rodrigues LC, Gourdine JP, Noll AJ, von Gunten S, Smith DF, Knirel YA, Paulson JC, Cummings RD (2014) Microbial glycan microarrays define key features of host-microbial interactions. Nat Chem Biol 10(6):470–476. https://doi.org/10.1038/nchembio.1525
Springer GF, Williamson P, Brandes WC (1961) Blood group activity of gram-negative bacteria. J Exp Med 113(6):1077–1093
Stowell CP, Stowell SR (2019) Biologic roles of the ABH and Lewis histo-blood group antigens part I: infection and immunity. Vox Sang 114(5):426–442. https://doi.org/10.1111/vox.12787
Stowell SR, Stowell CP (2019) Biologic roles of the ABH and Lewis histo-blood group antigens part II: thrombosis, cardiovascular disease and metabolism. Vox Sang 114(6):535–552. https://doi.org/10.1111/vox.12786
Quattroni P, Li Y, Lucchesi D, Lucas S, Hood DW, Herrmann M, Gabius HJ, Tang CM, Exley RM (2012) Galectin-3 binds Neisseria meningitidis and increases interaction with phagocytic cells. Cell Microbiol 14(11):1657–1675. https://doi.org/10.1111/j.1462-5822.2012.01838.x
Park AM, Hagiwara S, Hsu DK, Liu FT, Yoshie O (2016) Galectin-3 plays an important role in innate immunity to gastric infection by Helicobacter pylori. Infect Immun 84(4):1184–1193. https://doi.org/10.1128/IAI.01299-15
Fowler M, Thomas RJ, Atherton J, Roberts IS, High NJ (2006) Galectin-3 binds to Helicobacter pylori O-antigen: it is upregulated and rapidly secreted by gastric epithelial cells in response to H. pylori adhesion. Cell Microbiol 8(1):44–54. https://doi.org/10.1111/j.1462-5822.2005.00599.x
Yang ML, Chen YH, Wang SW, Huang YJ, Leu CH, Yeh NC, Chu CY, Lin CC, Shieh GS, Chen YL, Wang JR, Wang CH, Wu CL, Shiau AL (2011) Galectin-1 binds to influenza virus and ameliorates influenza virus pathogenesis. J Virol 85(19):10010–10020. https://doi.org/10.1128/JVI.00301-11
Chen Y, Zhou J, Cheng Z, Yang S, Chu H, Fan Y, Li C, Wong BH, Zheng S, Zhu Y, Yu F, Wang Y, Liu X, Gao H, Yu L, Tang L, Cui D, Hao K, Bosse Y, Obeidat M, Brandsma CA, Song YQ, To KK, Sham PC, Yuen KY, Li L (2015) Functional variants regulating LGALS1 (galectin 1) expression affect human susceptibility to influenza A(H7N9). Sci Rep 5:8517. https://doi.org/10.1038/srep08517
Levroney EL, Aguilar HC, Fulcher JA, Kohatsu L, Pace KE, Pang M, Gurney KB, Baum LG, Lee B (2005) Novel innate immune functions for galectin-1: galectin-1 inhibits cell fusion by Nipah virus envelope glycoproteins and augments dendritic cell secretion of proinflammatory cytokines. J Immunol 175(1):413–420. https://doi.org/10.4049/jimmunol.175.1.413
Garner OB, Aguilar HC, Fulcher JA, Levroney EL, Harrison R, Wright L, Robinson LR, Aspericueta V, Panico M, Haslam SM, Morris HR, Dell A, Lee B, Baum LG (2010) Endothelial galectin-1 binds to specific glycans on nipah virus fusion protein and inhibits maturation, mobility, and function to block syncytia formation. PLoS Pathog 6(7):e1000993. https://doi.org/10.1371/journal.ppat.1000993
Ouellet M, Mercier S, Pelletier I, Bounou S, Roy J, Hirabayashi J, Sato S, Tremblay MJ (2005) Galectin-1 acts as a soluble host factor that promotes HIV-1 infectivity through stabilization of virus attachment to host cells. J Immunol 174(7):4120–4126. https://doi.org/10.4049/jimmunol.174.7.4120
Wang SF, Tsao CH, Lin YT, Hsu DK, Chiang ML, Lo CH, Chien FC, Chen P, Arthur Chen YM, Chen HY, Liu FT (2014) Galectin-3 promotes HIV-1 budding via association with Alix and Gag p6. Glycobiology 24(11):1022–1035. https://doi.org/10.1093/glycob/cwu064
Montespan C, Marvin SA, Austin S, Burrage AM, Roger B, Rayne F, Faure M, Campell EM, Schneider C, Reimer R, Grunewald K, Wiethoff CM, Wodrich H (2017) Multi-layered control of Galectin-8 mediated autophagy during adenovirus cell entry through a conserved PPxY motif in the viral capsid. PLoS Pathog 13(2):e1006217. https://doi.org/10.1371/journal.ppat.1006217
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Verkerke, H., Dias-Baruffi, M., Cummings, R.D., Arthur, C.M., Stowell, S.R. (2022). Galectins: An Ancient Family of Carbohydrate Binding Proteins with Modern Functions. In: Stowell, S.R., Arthur, C.M., Cummings, R.D. (eds) Galectins. Methods in Molecular Biology, vol 2442. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-2055-7_1
Download citation
DOI: https://doi.org/10.1007/978-1-0716-2055-7_1
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-2054-0
Online ISBN: 978-1-0716-2055-7
eBook Packages: Springer Protocols